Eviation Aircraft debuts all-electric Alice at Paris Air Show
Israeli aerospace startup Eviation Aircraft has used the occasion of the Paris Air Show to debut its all electric aircraft, the Eviation Alice.
Described as a commuter plane with space for nine passengers, the all-electric Alice is said by Eviation to be the first of its kind. The plane will target “middle mile” routes, with the examples of internal flights such as Paris to Toulouse, Oslo to Trondheim and San Jose to San Diego being provided.
Eviation has collaborated with a number of companies on the aircraft, with Honeywell providing flight-by-wire systems, estimated position uncertainty systems from Siemens and magniX, propellers provided by Hartzell and landing gear from Magnahi Aeronautica.
"Capable of flying with 9 passengers at 240 knots and a range of up to 650 miles, we are thrilled to introduce Alice to the aviation world at the aviation industry's largest gathering,” said Eviation CEO, Omer Bar-Yohay. “Operating at a fraction of the costs of conventional jet liners, our Alice will redefine how people travel regionally and usher in a new era of flying that is quieter, cleaner and cost-effective. On behalf of the world-class group of suppliers within Alice's anatomy, we are humbled to recognize this debut as more than an unveiling - a historic milestone within the aviation industry. With the introduction of Alice, we welcome an all-new breed of airplanes for the first time in 50 years and it is only the beginning of a bright future for electric aviation and sustainable transportation."
Eviation said in its press release that it hoped to make electric aviation fast, sustainable and competitive with traditional aviation, both for passengers and cargo. Manufacturing is set to begin in the US in 2019, with the company aiming to bring the Alice to market in 2022.
IMF: Variants Can Still Hurt Manufacturing Recovery
After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022.
Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery.
Lingering Concerns Over COVID
Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high.
Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery?
IMF: Current Boom Could Falter
Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”.
Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”.
Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.